Since tubuloreticular structures (TRS) in the renal endothelium in systemic lupus erythematosus (SLE) were first described (Gy6key et al., 1969) there have been many reports of their presence in the cytoplasm of human lymphocytes. TRS have been found in the vascular endothelium and lymphocytes in various diseases of apparently independent pathogenesis (Schaff et al., 1973; Landolt et al., 1976) and there has been no convincing explanation for their presence. They have often been found in SLE (Gyorkey et al., 1972; Bariety et al., 1973; Grimley et al., 1973) and TRS in lymphocytes seem to be related to disease activity (Klippel et al., 1974) . However, they have been reported in only a few cases of rheumatoid arthritis (RA) (Gyorkey et al., 1972; Bariety et al., 1973) .
Another type of lymphocyte tubular inclusion are parallel tubular arrays (PTA). These have been found in lymphocytes of healthy persons (Huhn, 1968; Bariety et al., 1971; Brunning and Parkin, 1975) , but they are more common in various diseases (Brunning and Parkin 1975; Belcher et al., 1975) , particularly connective tissue diseases (Hovig et al., 1968; Bariety et al., 1971) .
Our aim was to ascertain the incidence of these TRS and PTA lymphocyte inclusions in RA and to Received for publication 31 January 1977 discover whether they were related to disease activity.
Patients and methods
Eighty patients with classical or definite RA according to the American Rheumatism Association (ARA) criteria (Ropes et al., 1958) were included in a prospective study. Of these 80 patients 14 had antinuclear antibodies (ANA) and a negative LE cell test, two had ANA and a positive LE cell test, and two had a positive LE cell test and no ANA. None other of the ARA preliminary criteria for SLE (Cohen et al., 1971) The ultrastructural pattern of the lymphocyte TRS was similar to that previously described. Inclusions (Fig. 1) were located in the endoplasmic reticulum or membranous compartments apparently connected with this reticulum. They had a net-like, reticular arrangement.The diameter of constituent tubules was 20 nm to 30 nm. The mean incidence of inclusions was much lower in RA (one positive cell for about 150 mononuclear cells) than in SLE (one positive cell for about 50 mononuclear cells).
Disease activity was compared in TRS-positive and TRS-negative patients with RA. No difference in ESR, rheumatoid factor concentration, or need for prednisone treatment was found.
LYMPHOCYTE PARALLEL TUBULAR ARRAYS PTA; were found 'in mononuclear cells in all the patients with RA and in all the SLE and healthy controls. In all the ultrastructural pattern of PTA was similar to that previously described. These inclusions (Fig. 2) consist of parallel arrays of tubular structures in wall-to-wall contact with each other. Arrays of tubules often appeared to be orientated at 900 to adjoining arrays within the same inclusion. The diameter of the constituent tubules was 15 nm to 30 nm. The inclusions, though usually bounded by membrane, sometimes had no limiting membrane. They were usually near to mitochondria, some of which had a degenerative pattern, or near the Golgi apparatus (Fig. 3) .
The number of PTA per mononuclear cell varied considerably from cell to cell. Rarely single, they were most often grouped in fair numbers. The number of PTA-positive cells differed considerably from subject to subject, varying from 1 to 8% of the mononuclear cells. However, the average number was similar in cases of RA, SLE, and in healthy controls.
Discussion

LYMPHOCYTE TUBULORETICULAR STRUCTURES
The significance of these structures remains obscure. Their resemblance to nucleocapsids of paramyxovirus was pointed out when they were first described (Gyorkey et al., 1969) , but further studies have refuted this analogy (Helder et al., 1975) . The biological nature of TRS has not been resolved. They may consist principally of phospholipids and acidic glycoproteins (Schaff et al., 1973) . The presence of nucleic acids has been suggested (Helder et al., 1975; Landolt et al., 1976) . They are most often found in patients with SLE, almost always in renal biopsies (Gyorkey et al., 1972; Bariety et al., 1973) and commonly in lymphocytes (Bariety et al., 1971; Gyorkey et al., 1972; Grimley et al., 1973) . The presence of TRS in the mononuclear cells of 10 of our 15 patients with SLE is in accordance with previous reports.
TRS seem to be uncommon in rheumatoid arthritis. Gyorkey et al. (1972) failed to find them in renal biopsies and Bariety et al. (1973) found them in only two out of six patients with RA. They were present in synovial membrane in four patients with RA (Gyorkey et al., 1972 ) but they were not found in another study of 24 patients with RA (Dryll et al., 1977) . Nor were they found in lymphocytes by Baridty et al. (1971) or by Grimley et al. (1973 The association of lymphocyte TRS, ANA, and LE cell phenomenon is often found in SLE. In our RA patients, ANA or LE cell phenomenon, or both, were significantly associated with lymphocyte TRS. Nine of the 13 TRS-positive RA patients had ANA and/or LE cell phenomenon and 9 of the 18 patients with ANA and/or LE cell phenomenon were TRS positive. The meaning of these associations in RA remain unclear. In spite of the absence of other criteria for SLE in all our patients the presence of lymphocyte TRS may provide further evidence for the existence of transitional forms between RA and SLE.
Disease activity has been found to be greater in patients with SLE when lymphocyte TRS were present than when they were not (Klippel et al., 1974) . In our patients with RA disease activity was the same in both TRS-positive and TRS-negative patients.
Immunosuppressive treatment possibly favours the appearance of TRS in renal biopsies (Bariety et al., 1974) . In our study chlorambucil treatment was significantly associated with lymphocyte TRS. Out of 13 RA patients treated with chlorambucil five were TRS positive. Two of the five had been TRS-negative before treatment. In two of the five ANA or LE phenomena were present. However, even when ANA or LE cell phenomena were absent the association between chlorambucil treatment and lymphocyte TRS remained significant.
LYMPHOCYTE PARALLEL TUBULAR ARRAYS
The significance of lymphocyte PTA is controversial. Huhn (1968) thought PTA were a new cytoplasmic organelle in normal lymphocytes. Hovig et al. (1968) thought they could be related to the RA or to the treatment, or both. White (1972 ), Belcher et al. (1975 ), and Brunning and Parkin (1975 suggested that, though present in normal lymphocytes, they might be more common in various diseases. Barietyet al. (1971) found PTA increased in SLE but they did not find them in RA. We found PTA in all patients with RA and SLE and in all healthy controls and the average number of PTA-bearing cells was similar.
The nature and the origin of these structures remain uncertain. The cytochemical study by Hovig et al. (1968) suggested that they might be phospholipidic in nature, Hovig et al. (1968) and Bariety et al. (1971) thought that they might originate from the mitochondria. White (1972) suggested they might be related to endoplasmic reticulum, and Brunning and Parkin (1975) that they might arise from the centriole. We have noticed only that these structures are often near mitochondria some of which have a degenerative pattern and the Golgi apparatus.
In conclusion, lymphocyte TRS are uncommon in RA. Their presence is significantly associated with ANA, LE cell phenomenon, and chlorambucil treatment. In TRS-positive cases the average number of cells with TRS was much lower in cases of RA than in those of SLE. On the other hand, PTA were present in all patients with RA and SLE and in all healthy controls, and the average number of PTA-bearing cells was the same in the three groups.
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